RU2014150071A - Способы кристаллизации для очистки моноклональных антител - Google Patents

Способы кристаллизации для очистки моноклональных антител Download PDF

Info

Publication number
RU2014150071A
RU2014150071A RU2014150071A RU2014150071A RU2014150071A RU 2014150071 A RU2014150071 A RU 2014150071A RU 2014150071 A RU2014150071 A RU 2014150071A RU 2014150071 A RU2014150071 A RU 2014150071A RU 2014150071 A RU2014150071 A RU 2014150071A
Authority
RU
Russia
Prior art keywords
buffer
paragraphs
composition
supernatant
ionic strength
Prior art date
Application number
RU2014150071A
Other languages
English (en)
Russian (ru)
Inventor
Дариуш ХЕКМАТ
Бернхард НЕЛЬК
Хенк Конрад ШУЛЬЦ
Бенджамин СМЕЙКАЛЬ
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of RU2014150071A publication Critical patent/RU2014150071A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D9/00Crystallisation
    • B01D9/005Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation
    • C07K1/306Extraction; Separation; Purification by precipitation by crystallization
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/16Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from plants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/54Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Botany (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
RU2014150071A 2012-05-11 2013-05-10 Способы кристаллизации для очистки моноклональных антител RU2014150071A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261645855P 2012-05-11 2012-05-11
US61/645,855 2012-05-11
PCT/EP2013/059696 WO2013167720A1 (en) 2012-05-11 2013-05-10 Crystallization methods for purification of monoclonal antibodies

Publications (1)

Publication Number Publication Date
RU2014150071A true RU2014150071A (ru) 2016-07-10

Family

ID=48326319

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014150071A RU2014150071A (ru) 2012-05-11 2013-05-10 Способы кристаллизации для очистки моноклональных антител

Country Status (14)

Country Link
US (2) US20150133642A1 (enExample)
EP (1) EP2846830A1 (enExample)
JP (1) JP2015517306A (enExample)
KR (1) KR20150016503A (enExample)
CN (1) CN104284676B (enExample)
AU (1) AU2013258006B2 (enExample)
BR (1) BR112014027994A2 (enExample)
CA (1) CA2872145A1 (enExample)
IL (1) IL235483A0 (enExample)
IN (1) IN2014DN09097A (enExample)
MX (1) MX2014013754A (enExample)
RU (1) RU2014150071A (enExample)
SG (1) SG11201406664SA (enExample)
WO (1) WO2013167720A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3015542A1 (de) * 2015-05-07 2016-05-04 Bayer Technology Services GmbH Modulare anlage und verfahren zur kontinuierlichen, keimreduzierten produktion und/oder aufbereitung eines produktes
JP7222891B2 (ja) * 2016-12-23 2023-02-15 アーラ フーズ エエムビエ 新規のベータ-ラクトグロブリン調製物の製造ならびに関連する方法、使用および食品
EP3596101B1 (en) * 2017-03-14 2022-01-05 Amgen Inc. Methods directed to crystalline biomolecules
PL3813549T3 (pl) 2018-06-27 2026-03-09 Arla Foods Amba Preparat napoju z beta-laktoglobuliną o obojętnym ph
JP7467438B2 (ja) 2018-10-18 2024-04-15 メルク・シャープ・アンド・ドーム・エルエルシー 抗rsv抗体の製剤及びその使用方法
CN113015748B (zh) 2018-10-31 2025-12-12 默沙东有限责任公司 抗人pd-1抗体晶体及其使用方法
IT202100004496A1 (it) 2021-02-25 2022-08-25 Univ Della Calabria Recupero di farmaci biologici o loro frammenti da soluzioni impure mediante cristallizzazione o precipitazione con membrane
CN116949036B (zh) * 2023-09-11 2023-12-15 成都斯马特科技有限公司 一种快速从腹水中提取核酸的试剂盒及提取方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4731793B2 (ja) * 2000-12-28 2011-07-27 アルセア テクノロジーズ インコーポレイテッド 抗体全体またはそのフラグメントの結晶、ならびにこの結晶を作製および使用するための方法
DE60237841D1 (de) * 2001-11-13 2010-11-11 Genentech Inc Zusammensetzungen basierend auf APO2-Ligand/ TRAIL und ihre Verwendung
US7087719B2 (en) * 2002-11-19 2006-08-08 Gtc Biotherapeutics, Inc. Method for the crystallization of human serum albumin
EP2235056A1 (en) * 2007-12-21 2010-10-06 Genentech, Inc. Crystallization of anti-cd20 antibodies
CN101320006B (zh) * 2008-07-17 2010-12-01 西北工业大学 蛋白质结晶条件的筛选方法

Also Published As

Publication number Publication date
EP2846830A1 (en) 2015-03-18
CN104284676A (zh) 2015-01-14
AU2013258006A1 (en) 2014-11-06
IN2014DN09097A (enExample) 2015-05-22
AU2013258006B2 (en) 2016-04-28
CN104284676B (zh) 2018-11-27
JP2015517306A (ja) 2015-06-22
MX2014013754A (es) 2015-02-12
WO2013167720A1 (en) 2013-11-14
KR20150016503A (ko) 2015-02-12
BR112014027994A2 (pt) 2017-06-27
US20170198028A1 (en) 2017-07-13
CA2872145A1 (en) 2013-11-14
IL235483A0 (en) 2014-12-31
SG11201406664SA (en) 2014-11-27
US20150133642A1 (en) 2015-05-14

Similar Documents

Publication Publication Date Title
RU2014150071A (ru) Способы кристаллизации для очистки моноклональных антител
JP2015517306A5 (enExample)
ES2533074T3 (es) Medio de cultivo celular mejorado
NZ580379A (en) Crystalline anti-human il-12 antibodies
JP6413024B2 (ja) D−プシコース結晶の製造方法
RU2009139054A (ru) ПРИМЕНЕНИЕ НИЗКОЙ ТЕМПЕРАТУРЫ И/ИЛИ НИЗКОГО pН В КУЛЬТУРЕ КЛЕТОК
RU2008152449A (ru) Получение гликопротеинов
RU2012141149A (ru) Способ очистки полипептидных растворов
EP4151645A3 (en) Separation of 2'-fl from a fermentation broth
CN101684569B (zh) 一种磷酸二氢钾类单晶体的生长方法及装置
RU2015144020A (ru) Среды для культивирования клеток и способы получения антител
RU2014135665A (ru) Способ получения иммуноглобулина человека
CN102168303A (zh) 一种提高110单晶硅成晶率的制备方法
CN102618924B (zh) 一种kdp类晶体侧向快速生长方法
CN101255120B (zh) 一种谷氨酸提取工艺
CN103436591B (zh) 以盐类作为沉淀剂用于蛋白质结晶筛选的试剂盒
CN102924312A (zh) 一种赖氨酸盐酸盐晶体及其生产方法
CN112851735B (zh) 氢化可的松的母料纯化方法
JPH0432078B2 (enExample)
KR20030093668A (ko) 동해 해양 심층수 소금
CN104211594B (zh) 一种提高l-古龙酸钠硫酸酸化提取效率的方法
Dhanasekaran et al. Nucleation control and growth of metastable α-L-glutamic acid single crystals in the presence of L-tyrosine
CN103553952B (zh) 一种溶液中α-氨基-对羟基苯乙酸的回收方法
CN103704453B (zh) 一种营养糖的制备方法
Gosavi et al. Distribution of Impurities in Protein Crystallization

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20190403